YM 215438

Drug Profile

YM 215438

Latest Information Update: 03 Sep 2004

Price : $50

At a glance

  • Originator Yamanouchi
  • Class Small molecules
  • Mechanism of Action Caspase-3 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Neurological disorders

Most Recent Events

  • 19 Jul 2004 Discontinued - Preclinical for Neurological disorders (Prevention) in Japan (unspecified route)
  • 17 Dec 2003 No development reported - Preclinical for Neurological disorders (Prevention) in Japan (unspecified route)
  • 18 Sep 2001 Preclinical development for Neurological disorders (Prevention) in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top